TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Due to the COVID-19 pandemic, the global Cancer Supportive Care Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Cancer Supportive Care Medicine market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Cancer Supportive Care Medicine landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Antiemetic Drugs accounting for % of the Cancer Supportive Care Medicine global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Chemotherapy-Induced Anemia segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2030.
The global major manufacturers of Cancer Supportive Care Medicine include Amgen, Helsinn Healthcare, Johnson &Johnson, Merck, F. Hoffmann-La Roche, GlaxoSmithKline, Heron Therapeutics, Kyowa Hakko Kirin and Novartis, etc. In terms of revenue, the global 3 largest players have a % market share of Cancer Supportive Care Medicine in 2022.
This report focuses on Cancer Supportive Care Medicine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cancer Supportive Care Medicine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Cancer Supportive Care Medicine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Segment by Application
By Region
By Company
